Journal of plastic, reconstructive & aesthetic surgery : JPRAS · 2025
3D-printed bioresorbable polycaprolactone-tricalcium phosphate implant for mandible reconstruction: A biomechanical in-vivo evaluation.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Cai Elijah Z, Yap Kwan Yi, Lee Zhi Peng, Yeo Jocelyn Yh, Liu Yu, Ong Zhi Xian, Wong Hung Chew, Lee Victor Km, Lim Thiam Chye
Аннотация
BACKGROUND: Large mandibular critical-sized defects commonly require free vascularized bone flaps. However, this procedure is associated with donor site morbidities and complex microsurgical procedures. An implant-based technique that can achieve similar reconstructive outcomes would be a valuable addition in a reconstructive surgeon's armamentarium. This preliminary study evaluated 3D-printed polycaprolactone-tricalcium phosphate implant for reconstructing mandibular critical-sized defects using a porcine model.
METHODS: Seven mandibular body critical-sized defects were created in 5 male Yorkshire-Landrace pigs (3 unilateral and 2 bilateral defects). These defects were reconstructed using polycaprolactone-tricalcium phosphate implants. The study endpoint was at 3 months. The reconstructed mandibular specimens were resected for evaluation. Ossification was evaluated using computed tomography scans and histology. Biomechanical strength was evaluated using the three-point bend test. The contralateral unoperated sides served as the controls.
RESULTS: The animals retained normal mastication. All implants demonstrated ossification on computed tomography scans with a median of 24.1% (range 13.6-27.2%). Histological examination (using hematoxylin and eosin and Masson's Trichrome stains) demonstrated new bone formation. The three-point bend test demonstrated a borderline significant difference in the maximum flexural force between the reconstructed mandibles and controls (p = 0.059), with a mean difference of 426.62 N (95% CI -16.57 to 869.81).
CONCLUSION: Using polycaprolactone-tricalcium phosphate implants in reconstructing mandibular critical-sized defects is safe and reliable. Polycaprolactone-tricalcium phosphate is bioresorbable, osteo-conductive, and osteo-inductive. It provides immediate functional restoration and mechanical strength under load-bearing situations.
METHODS: Seven mandibular body critical-sized defects were created in 5 male Yorkshire-Landrace pigs (3 unilateral and 2 bilateral defects). These defects were reconstructed using polycaprolactone-tricalcium phosphate implants. The study endpoint was at 3 months. The reconstructed mandibular specimens were resected for evaluation. Ossification was evaluated using computed tomography scans and histology. Biomechanical strength was evaluated using the three-point bend test. The contralateral unoperated sides served as the controls.
RESULTS: The animals retained normal mastication. All implants demonstrated ossification on computed tomography scans with a median of 24.1% (range 13.6-27.2%). Histological examination (using hematoxylin and eosin and Masson's Trichrome stains) demonstrated new bone formation. The three-point bend test demonstrated a borderline significant difference in the maximum flexural force between the reconstructed mandibles and controls (p = 0.059), with a mean difference of 426.62 N (95% CI -16.57 to 869.81).
CONCLUSION: Using polycaprolactone-tricalcium phosphate implants in reconstructing mandibular critical-sized defects is safe and reliable. Polycaprolactone-tricalcium phosphate is bioresorbable, osteo-conductive, and osteo-inductive. It provides immediate functional restoration and mechanical strength under load-bearing situations.